Advertisement
Optimi Health Corp.

Optimi Health Corp. Fundamental Analysis

OPTHNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$4.09
$0.03(0.74%)
U.S. Market opens in 54h 45m
Advertisement

Optimi Health Corp. Fundamental Analysis

Optimi Health Corp. (OPTH) shows weak financial fundamentals with a PE ratio of -3.46, profit margin of -23.30%, and ROE of -94.45%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio0.13

Areas of Concern

ROE-94.45%
Operating Margin-22.00%
Cash Position0.79%
Current Ratio0.06
We analyze OPTH's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2301.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2301.8/100

We analyze OPTH's fundamental strength across five key dimensions:

Efficiency Score

Weak

OPTH struggles to generate sufficient returns from assets.

ROA > 10%
-39.98%

Valuation Score

Excellent

OPTH trades at attractive valuation levels.

PE < 25
-3.46
PEG Ratio < 2
0.13

Growth Score

Weak

OPTH faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

OPTH carries high financial risk with limited liquidity.

Debt/Equity < 1
1.86
Current Ratio > 1
0.06

Profitability Score

Weak

OPTH struggles to sustain strong margins.

ROE > 15%
-9445.03%
Net Margin ≥ 15%
-23.30%
Positive Free Cash Flow
No

Key Financial Metrics

Is OPTH Expensive or Cheap?

P/E Ratio

OPTH trades at -3.46 times earnings. This suggests potential undervaluation.

-3.46

PEG Ratio

When adjusting for growth, OPTH's PEG of 0.13 indicates potential undervaluation.

0.13

Price to Book

The market values Optimi Health Corp. at 5.27 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.27

EV/EBITDA

Enterprise value stands at -3.39 times EBITDA. This is generally considered low.

-3.39

How Well Does OPTH Make Money?

Net Profit Margin

For every $100 in sales, Optimi Health Corp. keeps $-23.30 as profit after all expenses.

-23.30%

Operating Margin

Core operations generate -22.00 in profit for every $100 in revenue, before interest and taxes.

-22.00%

ROE

Management delivers $-94.45 in profit for every $100 of shareholder equity.

-94.45%

ROA

Optimi Health Corp. generates $-39.98 in profit for every $100 in assets, demonstrating efficient asset deployment.

-39.98%

Following the Money - Real Cash Generation

Operating Cash Flow

Optimi Health Corp. generates limited operating cash flow of $-3.21M, signaling weaker underlying cash strength.

$-3.21M

Free Cash Flow

Optimi Health Corp. generates weak or negative free cash flow of $-3.29M, restricting financial flexibility.

$-3.29M

FCF Per Share

Each share generates $-1.02 in free cash annually.

$-1.02

FCF Yield

OPTH converts -17.46% of its market value into free cash.

-17.46%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.46

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.13

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.27

vs 25 benchmark

P/S Ratio

Price to sales ratio

80.41

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.86

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.06

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.94

vs 25 benchmark

ROA

Return on assets percentage

-0.40

vs 25 benchmark

ROCE

Return on capital employed

-1.39

vs 25 benchmark

How OPTH Stacks Against Its Sector Peers

MetricOPTH ValueSector AveragePerformance
P/E Ratio-3.4629.63 Better (Cheaper)
ROE-94.45%223.00% Weak
Net Margin-2329.54%-38669.00% (disorted) Weak
Debt/Equity1.860.82 Weak (High Leverage)
Current Ratio0.064.30 Weak Liquidity
ROA-39.98%-379.00% (disorted) Weak

OPTH outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Optimi Health Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ